Weight loss drugs may help obese teens have less suicidal thoughts, study finds
A new study found that obese teens prescribed with weight loss drugs are less likely to have suicidal thoughts.
The FDA issued a warning about compounding pharmacies on weight-loss drugs
A surge of alternatives to newly popular weight-loss drugs is facing its biggest test yet after the FDA warned companies against skirting regulatory standards to put them on the market now that shortages are waning.
FDA says shortage of popular diabetes, weight-loss drugs resolved
The FDA says the shortage of tirzepatide injection — a glucagon-like peptide 1 medication used for diabetes and weight loss — has been resolved.
Eli Lilly’s weight-loss and diabetes drugs are no longer in shortage, says FDA
The U.S. Food and Drug Administration said Eli Lilly’s diabetes and weight-loss drugs marketed as Zepbound and Mounjaro are no longer in shortage signaling that the company has succeeded in expanding manufacturing.
Lilly's weight-loss drug removed from FDA's shortage list
The U.S. Food and Drug Administration removed Eli Lilly's blockbuster weight-loss and diabetes drugs from its shortage list late on Wednesday, likely piling pressure on firms selling cheaper versions known as compounded drugs.
Eli Lilly’s weight-loss drug no longer in shortage, FDA says
Eli Lilly’s (NYSE:LLY) blockbuster GLP-1 medication, tirzepatide, is no longer in shortage in the U.S., the U.S. Food and Drug Administration (FDA) said on Wednesday. Tirzepatide, currently marketed by Eli Lilly (LLY) as Mounjaro and Zepbound for diabetes and weight loss,
Weight-loss jabs ‘important for economy so people get back into work’, says PM
Weight-loss jabs ‘important for economy so people get back into work’, says PM - Sir Keir Starmer said anti-obesity ...
Teens With Obesity Less Likely to Be Suicidal on Weight Loss Drugs: Study
Weight loss drugs like Ozempic were associated with a lower risk of suicidal thoughts in teens with obesity, a new study found.
Medscape1h
Obesity Therapies: What Will the Future Bring?
Obesity treatment should start at a young age, he said, because if you have overweight at ages 3-6 years, the likelihood of ...
News Medical on MSN11h
Dietitians boost GLP-1 therapy success with personalized care and side effect management
Researchers reveal the importance of personalized communication and side effect management in improving outcomes for patients ...
tyla1d
Doctor issues devastating warning of ‘overlooked’ side effects of using Ozempic
Wylie said: "Ozempic (semaglutide) is a medication licensed for the management of type 2 diabetes. While it has shown ...
ahajournals.org4d
Muscle Mass and Glucagon-Like Peptide-1 Receptor Agonists: Adaptive or Maladaptive Response to Weight Loss?
Recent studies have shown that pharmacologic weight loss with glucagon-like peptide-1 receptor agonists (GLP-1 RAs) and combination therapies is approaching magnitudes achieved with surgery. However, ...
News Medical on MSN13h
Semaglutide enhances cognitive abilities and reduces Alzheimer’s pathology in mice and human brain models
Researchers find that Semaglutide improves cognitive function and reduces amyloid and tau pathology in Alzheimer's disease ...
Anti-obesity drugs like Ozempic 'tied to lower risk of suicidal thoughts'
GLP-1 agonists work by suppressing patients’ appetites and have been approved to treat obesity and type 2 diabetes in the ...
Pharmaceutical Technology1mon
Glucagon Like Peptide 1 drugs in development, 2024
GlobalData’s report assesses the drugs in the Glucagon Like Peptide 1 pipeline by therapy areas, indications, stages, MoA, RoA, molecule type and the key players in the development pipeline.
Metro on MSN8h
Unemployed people to be given weight loss jabs to ‘get them back to work’
Mounjaro, which is made by Eli Lilly, is a glucagon-like peptide-1 (GLP-1) agonist, a family of medications that help ...
Modern Healthcare4d
This is what buyers of digital health solutions want in a partner
Most digital health purchasers plan to increase their investments next year and are asking for risk-based contracts.
The American Journal of Managed Care4d
Legislative Updates, GLP-1s, and More at AMCP Nexus: Adam Colborn
Speakers from across the care continuum will discuss legislative updates, glucagon-like peptide-1 (GLP-1) use for weight management, and more at this year’s AMCP Nexus.